A top F.D.A. regulator said there was compelling data for redesigned coronavirus vaccines from Pfizer-BioNTech and Moderna. www.nytimes.com
A top F.D.A. regulator said there was compelling data for redesigned coronavirus vaccines from Pfizer-BioNTech and Moderna.
www.nytimes.com